Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis.

Leeflang MM, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, Van Burgel ND, Van Dam AP, Dessau RB, Fingerle V, Hovius JW, Jaulhac B, Meijer B, Van Pelt W, Schellekens JF, Spijker R, Stelma FF, Stanek G, Verduyn-Lunel F, Zeller H, Sprong H.

BMC Infect Dis. 2016 Mar 25;16:140. doi: 10.1186/s12879-016-1468-4. Review.

2.

Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Leeflang MM, Debets-Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Zhang M, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2015 Dec 30;(12):CD007394. doi: 10.1002/14651858.CD007394.pub2. Review.

3.

A Dutch nationwide evaluation of serological assays for detection of Borrelia antibodies in clinically well-defined patients.

Ang CW, Brandenburg AH, van Burgel ND, Bijlmer HA, Herremans T, Stelma F, Lunel FV, van Dam AP; Dutch Working Group on Diagnosis of Lyme Borreliosis.

Diagn Microbiol Infect Dis. 2015 Nov;83(3):222-8. doi: 10.1016/j.diagmicrobio.2015.07.007. Epub 2015 Jul 17.

PMID:
26286381
4.

Immunogenicity of the Q fever skin test.

Schoffelen T, Herremans T, Sprong T, Nabuurs-Franssen M, van der Meer JW, Joosten LA, Netea MG, Bijlmer HA, van Deuren M.

J Infect. 2014 Aug;69(2):161-4. doi: 10.1016/j.jinf.2014.03.008. Epub 2014 Mar 15.

PMID:
24642208
5.

Successful control of a hospital-wide outbreak of OXA-48 producing Enterobacteriaceae in the Netherlands, 2009 to 2011.

Dautzenberg MJ, Ossewaarde JM, de Kraker ME, van der Zee A, van Burgh S, de Greeff SC, Bijlmer HA, Grundmann H, Cohen Stuart JW, Fluit AC, Troelstra A, Bonten MJ.

Euro Surveill. 2014 Mar 6;19(9). pii: 20723.

6.

A dynamic case definition is warranted for adequate notification in an extended epidemic setting: the Dutch Q fever outbreak 2007-2009 as exemplar.

Jaramillo-Gutierrez G, Wegdam-Blans MC, ter Schegget R, Korbeeck JM, van Aken R, Bijlmer HA, Tjhie JH, Koopmans MP.

Euro Surveill. 2013 Oct 10;18(41):20606.

7.

A combination of interferon-gamma and interleukin-2 production by Coxiella burnetii-stimulated circulating cells discriminates between chronic Q fever and past Q fever.

Schoffelen T, Sprong T, Bleeker-Rovers CP, Wegdam-Blans MC, Ammerdorffer A, Pronk MJ, Soethoudt YE, van Kasteren ME, Herremans T, Bijlmer HA, Netea MG, van der Meer JW, Joosten LA, van Deuren M.

Clin Microbiol Infect. 2014 Jul;20(7):642-50. doi: 10.1111/1469-0691.12423. Epub 2013 Nov 18.

8.

Limited humoral and cellular responses to Q fever vaccination in older adults with risk factors for chronic Q fever.

Schoffelen T, Herremans T, Sprong T, Nabuurs-Franssen M, Wever PC, Joosten LA, Netea MG, van der Meer JW, Bijlmer HA, van Deuren M.

J Infect. 2013 Dec;67(6):565-73. doi: 10.1016/j.jinf.2013.08.008. Epub 2013 Aug 22.

PMID:
23973626
9.

Defining chronic Q fever: a matter of debate.

Kampschreur LM, Wever PC, Wegdam-Blans MC, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Coutinho RA, Schneeberger PM, Notermans DW, Bijlmer HA, Koopmans MP, Nabuurs-Franssen MH, Oosterheert JJ.

J Infect. 2012 Oct;65(4):362-3. doi: 10.1016/j.jinf.2012.08.002. Epub 2012 Aug 13. No abstract available.

PMID:
22898388
10.

Evaluation of commonly used serological tests for detection of Coxiella burnetii antibodies in well-defined acute and follow-up sera.

Wegdam-Blans MC, Wielders CC, Meekelenkamp J, Korbeeck JM, Herremans T, Tjhie HT, Bijlmer HA, Koopmans MP, Schneeberger PM.

Clin Vaccine Immunol. 2012 Jul;19(7):1110-5. doi: 10.1128/CVI.05581-11. Epub 2012 May 23.

11.

Shifting priorities in the aftermath of a Q fever epidemic in 2007 to 2009 in The Netherlands: from acute to chronic infection.

van der Hoek W, Schneeberger PM, Oomen T, Wegdam-Blans MC, Dijkstra F, Notermans DW, Bijlmer HA, Groeneveld K, Wijkmans CJ, Rietveld A, Kampschreur LM, van Duynhoven Y.

Euro Surveill. 2012 Jan 19;17(3):20059. Review.

12.

Chronic Q fever: review of the literature and a proposal of new diagnostic criteria.

Wegdam-Blans MC, Kampschreur LM, Delsing CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, Notermans DW, Renders NH, Bijlmer HA, Lestrade PJ, Koopmans MP, Nabuurs-Franssen MH, Oosterheert JJ; Dutch Q fever Consensus Group.

J Infect. 2012 Mar;64(3):247-59. doi: 10.1016/j.jinf.2011.12.014. Epub 2011 Dec 23. Review.

PMID:
22226692
13.

[Laboratory diagnosis of acute Q fever].

Wegdam-Blans MC, Nabuurs-Franssen MN, Horrevorts AM, Peeters MF, Schneeberger PM, Bijlmer HA.

Ned Tijdschr Geneeskd. 2010;154:A2388. Review. Dutch.

PMID:
20858325
14.

[What does it mean 'sensitive'? Failing ciprofloxacin in typhus abdominalis].

van 't Wout JW, Jones JO, Visser LG, Bijlmer HA, Veldkamp PJ, van Dissel JT.

Ned Tijdschr Geneeskd. 2009 May 9;153(19):914-8. Dutch. No abstract available.

PMID:
19489296
15.

Galactomannan detection for invasive aspergillosis in immunocompromized patients.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007394. doi: 10.1002/14651858.CD007394. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007394.

PMID:
18843747
16.

Changing epidemiology of melioidosis? A case of acute pulmonary melioidosis with fatal outcome imported from Brazil.

Aardema H, Luijnenburg EM, Salm EF, Bijlmer HA, Visser CE, Van't Wout JW.

Epidemiol Infect. 2005 Oct;133(5):871-5.

17.

Bacteremia due to Streptococcus gallolyticus, or the perils of revised nomenclature in bacteriology.

van't Wout JW, Bijlmer HA.

Clin Infect Dis. 2005 Apr 1;40(7):1070-1. No abstract available.

PMID:
15825011
18.

Upper respiratory tract infection, heterologous immunisation and meningococcal disease.

Scholten RJ, Bijlmer HA, Tobi H, Dankert J, Bouter LM.

J Med Microbiol. 1999 Oct;48(10):943-6.

PMID:
10510971
19.

[Campylobacter infections in pregnancy].

Corel LJ, Horrevorts AM, Beyer GP, Valentijn RM, Bijlmer HA.

Ned Tijdschr Geneeskd. 1996 Dec 14;140(50):2517-9. Dutch.

PMID:
9005335
20.

Prognostic indicators of the outcome of meningococcal disease: a study of 562 patients.

Lodder MC, Schildkamp RL, Bijlmer HA, Dankert J, Kuik DJ, Scholten RJ.

J Med Microbiol. 1996 Jul;45(1):16-20.

PMID:
8667405
21.

[Myiasis caused by Dermatobia hominis].

Horrevorts AM, Boutkan H, Breslau PJ, Bijlmer HA.

Ned Tijdschr Geneeskd. 1996 May 18;140(20):1083-5. Dutch.

PMID:
8692327
22.

Clinical manifestations and course of meningococcal disease in 562 patients.

Schildkamp RL, Lodder MC, Bijlmer HA, Dankert J, Scholten RJ.

Scand J Infect Dis. 1996;28(1):47-51.

PMID:
9122633
23.

Antibody responses to the capsular polysaccharide of Neisseria meningitidis serogroup B in patients with meningococcal disease.

Granoff DM, Kelsey SK, Bijlmer HA, Van Alphen L, Dankert J, Mandrell RE, Azmi FH, Scholten RJ.

Clin Diagn Lab Immunol. 1995 Sep;2(5):574-82.

24.

Excess female fatalities among patients with meningococcal disease.

Scholten RJ, Bijlmer HA.

Int J Epidemiol. 1995 Feb;24(1):244-5. No abstract available.

PMID:
7797352
25.

Antibiotic susceptibility of invasive and non-invasive isolates of Haemophilus influenzae from the Gambia, west Africa.

Bijlmer HA, van Alphen L, Greenwood BM, Geelen-van den Broek L, Valkenburg HA, Dankert J.

J Antimicrob Chemother. 1994 Aug;34(2):275-80. No abstract available.

PMID:
7814289
26.

Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990.

Scholten RJ, Poolman JT, Valkenburg HA, Bijlmer HA, Dankert J, Caugant DA.

J Infect Dis. 1994 Mar;169(3):673-6.

PMID:
8158049
27.

Patient and strain characteristics in relation to the outcome of meningococcal disease: a multivariate analysis.

Scholten RJ, Bijlmer HA, Valkenburg HA, Dankert J.

Epidemiol Infect. 1994 Feb;112(1):115-24.

28.

[Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].

Scholten RJ, Bijlmer HA, Dankert J, Valkenburg HA.

Ned Tijdschr Geneeskd. 1993 Jul 24;137(30):1505-8. Dutch.

PMID:
8366938
29.

Postoperative cauda syndrome caused by Staphylococcus aureus.

Arend SM, Steenmeyer AV, Mosmans PC, Bijlmer HA, van't Wout JW.

Infection. 1993 Jul-Aug;21(4):248-50.

PMID:
8225630
30.

Meningococcal disease in The Netherlands, 1958-1990: a steady increase in the incidence since 1982 partially caused by new serotypes and subtypes of Neisseria meningitidis.

Scholten RJ, Bijlmer HA, Poolman JT, Kuipers B, Caugant DA, Van Alphen L, Dankert J, Valkenburg HA.

Clin Infect Dis. 1993 Feb;16(2):237-46.

PMID:
8443302
31.
32.

Molecular epidemiology of Haemophilus influenzae type b in the Gambia.

Bijlmer HA, van Alphen L, Geelen-van den Broek L, Greenwood BM, Valkenburg HA, Dankert J.

J Clin Microbiol. 1992 Feb;30(2):386-90.

33.
34.

The epidemiology of Haemophilus influenzae meningitis in children under five years of age in The Gambia, West Africa.

Bijlmer HA, van Alphen L, Greenwood BM, Brown J, Schneider G, Hughes A, Menon A, Zanen HC, Valkenburg HA.

J Infect Dis. 1990 Jun;161(6):1210-5.

PMID:
2345302
35.

Molecular epidemiology of Haemophilus influenzae type b.

van Alphen L, Bijlmer HA.

Pediatrics. 1990 Apr;85(4 Pt 2):636-42. Review.

PMID:
2179853
36.

[Meningococcal disease in the winter season 1988-1989].

Postema CA, Bilkert-Mooiman MA, Bijlmer HA.

Ned Tijdschr Geneeskd. 1990 Mar 24;134(12):609-13. Dutch.

PMID:
2320163
37.

Carriage of Haemophilus influenzae in healthy Gambian children.

Bijlmer HA, Evans NL, Campbell H, Van Alphen L, Greenwood BM, Valkenburg HA, Zanen HC.

Trans R Soc Trop Med Hyg. 1989 Nov-Dec;83(6):831-5.

PMID:
2617654
38.

Low frequency of erythromycin-resistant Streptococcus pneumoniae in The Netherlands.

Endtz HP, Peetermans WE, Bijlmer HA.

Lancet. 1989 May 20;1(8647):1144-5. No abstract available.

PMID:
2566090
39.

Malnutrition and diarrhoea in Nepal.

Leentjens AF, van der Heijden AM, van Loon NH, Veldhuijsen J, Veldhuijsen-De Vries J, Valkenburg HA, Vos E, Heijnen HA, Bijlmer HA, Heineman E.

J Trop Pediatr. 1988 Jun;34(3):135-6. doi: 10.1093/tropej/34.3.135. No abstract available.

PMID:
3404575
40.

The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa.

Greenwood BM, Smith AW, Hassan-King M, Bijlmer HA, Shenton FC, Hughes AS, Nunn PP, Jack AD, Gowers PR.

Trans R Soc Trop Med Hyg. 1986;80(6):1006-7. No abstract available.

PMID:
3603632

Supplemental Content

Loading ...
Support Center